Sort
48,018 grants matching “immunotherapy”
Examining IgG4 sialylation as a gain of function post-translation modification in IgG4-related diseases
$822,968Robert McCullough Anthony · Massachusetts General Hospital · R01 · FY2023 · AI
Examining IgG4 sialylation as a gain of function post-translation modification in IgG4-related diseases
$822,968Robert McCullough Anthony · Massachusetts General Hospital · R01 · FY2021 · AI
Examining IgG4 sialylation as a gain of function post-translation modification in IgG4-related diseases
$822,968Robert McCullough Anthony · Massachusetts General Hospital · R01 · FY2024 · AI
Targeting Neuroblastoma with armed T cells
$822,924Lawrence G Lum · University Of Virginia · R01 · FY2016 · CA
Trinity: Transcriptome assembly for genetic and functional analysis of cancer
$822,764Brian Haas · Broad Institute, Inc. · U24 · FY2021 · CA
First-in-human study of a potent anti-HBsAg neutralizing antibody
$822,075Marina Caskey · Rockefeller University · U01 · FY2025 · AI
Development of Novel Therapies for Acute Lymphoblastic Leukemia
$822,033Nirali Shah · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Advancing treatment and understanding of immunotherapy in glioblastoma
$821,970Nicholas A Butowski · University Of California, San Francisco · U19 · FY2023 · CA
Advancing treatment and understanding of immunotherapy in glioblastoma
$821,968Nicholas A Butowski · University Of California, San Francisco · U19 · FY2022 · CA
Immunoprevention and immunosurveillance of human non-viral cancers
$821,873Olivera J Finn · University Of Pittsburgh At Pittsburgh · R35 · FY2021 · CA
Exploring Siglec-glycan ligand interactions using chemoenzymatic approaches
$821,772Peng Wu · Scripps Research Institute, The · R01 · FY2025 · AI
Engineering HCC-selective PET agent
$821,745Freddy Escorcia · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
CONTROL AND ACTIVATION OF THE TUMOR NECROSIS FACTOR RECEPTORS
$821,630James J Chou · Harvard Medical School · R01 · FY2020 · AI
Immune Mechanisms, Genetic and Environmental Factors Influencing Outcomes
$821,630Scott H Sicherer · Icahn School Of Medicine At Mount Sinai · U19 · FY2014 · AI
Immune epigenetic biomarkers of survival in glioma epidemiology
$821,594John K. Wiencke · University Of California, San Francisco · R01 · FY2019 · CA
Hepatitis C: Studies of Immunity and Pathogenesis
$821,545Charles M. Rice · Rockefeller University · U19 · FY2009 · AI
IMMUNE FUNCTION AND LOW RISK GENOTYPES IN IDD
$821,383University Of Florida · P01 · FY2000 · AI
Single-Cell Analysis of the HIV/SIV Reservoir
$821,117Dan H. Barouch · Beth Israel Deaconess Medical Center · R01 · FY2022 · AI
Single-Cell Analysis of the HIV/SIV Reservoir
$821,117Dan H. Barouch · Beth Israel Deaconess Medical Center · R01 · FY2024 · AI
Single-Cell Analysis of the HIV/SIV Reservoir
$821,117Dan H. Barouch · Beth Israel Deaconess Medical Center · R01 · FY2023 · AI
Single-Cell Analysis of the HIV/SIV Reservoir
$821,117Dan H. Barouch · Beth Israel Deaconess Medical Center · R01 · FY2021 · AI
Proteogenomic translator for cancer biomarker discovery towards precision medicine
$821,000Pei Wang · Icahn School Of Medicine At Mount Sinai · U24 · FY2025 · CA
Evolution of T cell immunity in blood and tissues over childhood
$820,875Donna L Farber · Columbia University Health Sciences · U01 · FY2022 · AI
Immunotherapy for Malignant Mesothelioma, Lung Cancer and Thymic Malignancies
$820,478Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Immunologic and Antigenic Drivers of Immune Checkpoint Inhibitor-Associated Myocarditis
$820,373Justin M Balko · Vanderbilt University Medical Center · R01 · FY2022 · HL